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Abstract 
Atlantic salmon smelts (Salmo salar) were vaccinated with a bac-
terin made from formalin-killed Vibrio salmonicida. In labora-
tory trials, fish vaccinated once showed little or no protection 
after challenge. Fish vaccinated twice appeared to be protected, 
the degree of protection depending on the administration route 
of the. vaccine. 
Introduction 
Since the late seventies, the farmed Norwegian salmon have suffe-
red from Hitra disease. In 1986-87 the mortality reached 50-90% 
in several fish farms in mid and northern Norway. The etiology 
has been discussed but part of the confusion may be due to dif-
ferent diseases producing same symptoms. One of these diseases 
is undoubtedly a vibrio infection - 11 Coldwater Vibriosis". 
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·In 1981, Egidius et al. isolated a vibrio-like bacteria from fish 
suffering from Hitra disease. This Vibrio ~· was characterized 
by Holm et al (1985) and by Egidius et al (1986) who proposed 
a new species Vibrio salmonicida. Infection studies on rainbow 
trout (Egidius et al 1981) and on Atlantic salmon (Hjeltnes et 
al 1987) showed it to be a fish pathogen capable of producing 
symptoms similar to Hitra disease. 
Holm and J~rgensen (1987) report on resistance after double 
dip vaccination with a bacteria developed from a strain of V. 
salmonicida. The efficiency was recorded after a natural epi-
zootic. The purpose of the present study was to evaluate by 
laboratory trials the effect of vaccination against Vibrio sal-
moncida with special attention to revaccination and administra-
tion routes. 
Materials and methods 
Fish 
The fish were 18-24 cm (80 g) Atlantic salmon smolts kept in 
UV-treated seawater with a salinity of 30 o/oo in 200 1 or 400 
1 aquaria. They were fed Ewos dry pellets and were actively 
feeding before challenge. 
Vaccines 
Whole cell vaccines were prepared from Vibrio salmonicida by 
growing the cells in a liquid medium and killed by adding forma-
lin (0.5 %). The cells were not washed before used as a bacte-
rin. Vaccine A was prepared in our laboratorium from type 
strain NCMB 2262 grown to a density of 5.5 x 108 · 5 cells/m! in 
tryptone soy broth (TSB, Oxoid) with 15 o/oo NaCl added. 
Vaccine B was prepared by A/S Apothekernes Laboratorium, Oslo, 
Norway in an industrial-scale fermentor (1.200 liters, Holm 
and J~rgensen 1987). 
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Vaccination 
Bath vaccination was performed as described by Egidius and 
Andersen (1979) with a dilution of 1:200. 
Dip vaccination was performed by immersing the fish one minute 
in a 1:5 dilution of the vaccine. Injection was performed by 
i.p. injection of 0.2 ml undiluted vaccine. 
Challenge 
Waterborne challenge was performed by exposing the fish to 5 
x 10 5 bacteria/m! for 1 hr. When injection was used as a chal-
lenge, 0.2 ml of 10 bacteria/m! was injected i.p. Dead and mori-
bund fish were collected and bacterial cultivation from the 
kidneys was attempted on tryptone soy (TS) agar with 5 % human 
blood and 15 o/oo NaCl and grown at 15° c. 2-3 months after 
challenge, survivors were examined for the presence of bacteria 
in the kidneys. 
Experiment 1 
Fish were bath Vaccinated with vaccine B at 8. 5 ° C and kept at 
this temperature four weeks after vaccination. 
given a waterborne challenge. 
Experiment 2 
The fish were 
Fish were bath vaccinated with Vaccine A at 5 °c and kept at 
this temperature for four weeks. After four months, fish were 
revaccinated by bath or by injection at 7.5 °c. Groups of these 
fish were challenged by injection fifteen weeks after the first 
vaccination and six weeks after revaccination. 
Experiment 3 
Fish were vaccinated by dip and i .p. injection with Vaccine B 
at 12 ° C. After 8 weeks, · the fish were revaccinated by bath, 
dip and injection at 7.5 6 c. Six weeks after revaccination, the 




A single' bath vaccination did not appear to give any significant 
protection although a small difference was observed (Tab. 1) . 
Experiment 2 
Again a single bath vaccination did not appear to give any si-
gnificant protection against infection by V. salmonicida 
although some improvement was observed during the later challenge 
(Table 2). Revaccination by bath gave good protection and 
revaccination by injection apparently gave total protection. 
Experiment 3 
In this experiment the mortality in the control group was not 
very high (34 %) but some differences among the groups were 
observed (Tab. 3). 
A single dip vaccination did not give good protection. A single 
injection gave some protection but not as good as the revaccina-
ted groups.. Injection followed by a dip vaccination gave the 
best resistance .. 
Vibrio salmonicida was cultivated from the kidneys of all dead 




Table 1. Experiment 1.. Mortality in unvaccinated and single 
bath vaccinated after waterborne challenge (NCMB 2262) 




















Table 2. Experiment 2o Mortality in unvaccinated and vaccinated 
fish after challenge by i.p. injection. 
* Challenged 15 weeks after 1st vaccination (NCMB 2262) 
** Challenged 6 weeks after 2nd vaccination (NCMB 2262) 
Treatment (Vacc. A) 
1. 2 .. No of fish Mortality % 
I Unvaccinated 46 24 52.1 
Bath 43 18 41.8 
Unvaccinated 45 43 95.5 
Bath 29 20 68.9 
** II Bath Bath 37 10 27.0 
Bath Injection 41 0 0 
- 6 -
Table 3. Experiment 3. Mortality in unvaccinated and vaccinated 
fish after challenge by i .p. injection (LFI 001). 
Treatment (Vacc. B) 
1. 2. No of fish Mortality % 
Unvaccinated 44 15 34.1 
Dip 45 10 22.3 
Dip Bath 45 6 13.4 
Injection 36 3 8.3 
Dip Dip 47 3 6.4 
Dip Injection 44 2 4.6 
Injection Dip 34 0 0 
Discussion 
The Hitra disease is economically the most important disease in 
Norwegian fish farming. Because prompt therapy is essential, 
medical treatment has been difficult. Since 1985 multiple-re-
sistant strains of Vibrio salmonicida have been reported 
(Hjeltnes et al. 1987). The incidence of multiple-resistant 
strains seems to be increasing and this emphasizes the need for 
a vaccine .. 
Under laboratory conditions, Atlantic salmon can be effectively 
vaccinated against Vibrio salmonicida, although a single bath or 
dip vaccination gives little or no protection. As regards vac-
cination by single injection, the data are too limited for any 
firm conclusion before further investigation. Revaccinated 
fish are protected against Vibrio salmonicida. The degree of 
protection depending on the administration route of the vaccine. 
This supports the observation of Holm and J~rgensen (1987) who 
found in a field test that double dip vaccinated Atlantic salmon 
were protected against "Cold-Water Vibriosis ... 
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. The increased protection observed from booster vaccination indi-
cates a secondary immune response in Atlantic salmon. The best 
protection was observed from combinations of bath and injection 
or dip and injection. Different ways of stimulating the immune 
system may be responsible for this increased protection. 
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